fb-pixel tracker
News

Caris Life Sciences Showcases Results from Novel Machine Learning Approach to Classify Cancer by Molecular Signatures

Caris Next Generation Profiling enables a proprietary algorithm to accurately classify tumors, demonstrating improvement in cancer diagnosis CHICAGO, Ill., June 1, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today presented a poster demonstrating how its advanced machine learning approach, Caris Next Generation Profiling, … Continued

Caris Life Sciences Partners with Debiopharm International SA to Develop Companion Diagnostic for Detection of Rare FGFR Fusions Using Novel Molecular Intelligence (MI) Transcriptome™

Caris to develop CDx for Debiopharm’s FUZE Phase II Pivotal Trial of Debio 1347 in solid tumor patients with FGFR fusions IRVING, Texas, May 30, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced that it has entered into a strategic collaboration with … Continued

Caris Life Sciences to Present New Research at ASCO 2019

Findings in molecular science will advance and reinvent cancer care for patients IRVING, Texas, May 21, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that it will present new findings to advance and reinvent cancer care at the 2019 American Society of … Continued

Brown University Joins Caris Life Sciences’ Precision Oncology Alliance

Esteemed academic institution with decades of leadership in cancer care innovation will strengthen the power of the collaborative network to advance precision medicine IRVING, Texas, May 14, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, announced today that Brown University has become the 27th … Continued

Caris Life Sciences Acquires Pharmatech

Purchase of leading Just-In-Time clinical trials recruitment service will benefit patients, physicians and drug developers by connecting cancer patients to the right trials faster IRVING, Texas, May 1, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced that it has acquired Pharmatech, Inc., … Continued

Joseph J. Frendo Joins Caris Life Sciences as Chief Operations Officer

Healthcare veteran joins leading molecular science company IRVING, Texas, April 23, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced that Joseph J. Frendo has joined the company as Chief Operations Officer. In his role, Frendo will oversee and direct all technical and … Continued

Caris Life Sciences Identifies a Splicing Complex on the Surface of Non-Hodgkin’s Lymphoma Cells that Is a Potential Anti-Tumor Drug Target

Findings from Caris Life Sciences and University of Bonn, published in Cell Chemical Biology, demonstrate for the first time a spliceosomal complex identified on surface of cancer cells IRVING, Texas, March 28, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced the publication … Continued

Caris Life Sciences to Present Initial Study Results for Blood-Based Prostate Cancer Test at AACR Annual Meeting

Caris scientists and collaborators to also present posters on colorectal cancer biomarkers, mutations in the CYLD gene, mutations in head and neck squamous cell carcinoma, and PD-L1 expression IRVING, Texas, March 27, 2019 – Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced that it will … Continued

1 2 3 4 20

About Our News

Search to find the latest new about Caris Molecular Intelligence®, sign up for news alerts, and be sure to follow us on social media.